文献速递中枢神经肿瘤放疗放疗物理与技术

脑转移瘤伽玛刀治疗中面罩与框架固定的前瞻性评估

Prospective assessment of mask versus frame fixation during Gamma Knife treatment for brain metastases.
PubMed 文献 · Radiother Oncol · 2020-05-19

这项前瞻性非随机研究比较了脑转移瘤伽玛刀治疗中面罩固定与框架固定的结局,共治疗76例患者的197个病灶。结果显示面罩固定组局部失败率更低(HR 3.69,95%CI 1.13-12.0,p=0.03),总生存和无进展生存无差异,放射性坏死发生率无差异。

要点

  • 面罩固定组局部失败率显著低于框架固定组(HR 3.69,95%CI 1.13-12.0,p=0.03)。
  • 两组总生存和无进展生存无显著差异。
  • 放射性坏死发生率两组无显著差异(p=0.67)。

核心结论

  • 在这项非随机研究中,面罩固定伽玛刀治疗未导致更差的结局或放射性坏死率增加。

研究设计与样本

  • 前瞻性非随机研究,76例患者共197个脑转移病灶,其中框架固定169个病灶(59例),面罩固定28个病灶(17例)。
  • 固定方式根据患者偏好、关键结构邻近度、V12和治疗时间个案决定,行立体定向放射外科或最多3次的分次立体定向放疗。
  • 面罩固定组计划靶区(PTV)外扩1 mm,随访包括每季度MRI扫描。

主要发现

  • 框架固定组出现11例局部失败,面罩固定组无局部失败,局部失败率框架固定组更高(HR 3.69;95%CI 1.13-12.0;p=0.03)。
  • 总生存两组无差异(中位:未达到 vs 16.9个月;HR 1.00;95%CI 0.41-2.46;p=0.999)。
  • 无进展生存两组无差异(中位:6.9 vs 8.4个月;HR 0.92;95%CI 0.47-1.79;p=0.800)。
  • 放射性坏死框架固定组3例,面罩固定组0例(p=0.67)。

关键数值与推荐

  • 共197个病灶(框架固定169个,面罩固定28个)在76例患者(框架固定59例,面罩固定17例)中治疗。
  • 187个病灶接受立体定向放射外科,10个接受分次立体定向放疗,两组中位剂量均为22 Gy,中位随访9.3个月。
  • 面罩固定组PTV外扩1 mm,随访包括每季度MRI扫描。

临床怎么用

  • 面罩固定可作为脑转移瘤伽玛刀治疗的可行选择,需结合患者偏好、关键结构邻近度、V12和治疗时间个案决定。
  • 面罩固定时需增加1 mm的PTV外扩,并定期MRI随访监测局部失败。

局限性

  • 本研究为非随机研究,面罩固定组样本量较小(28个病灶,17例患者)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The newest generation of the Leksell Gamma Knife (GK) allows frame based as well as frameless treatment. We here report outcomes of a prospective non-randomized study on mask fixation (MF) versus frame fixation (FF) for GK treatment of brain metastases. METHODS: The decision for FF or MF was made on a case-by-case basis. Factors considered were patients' preference, proximity of critical structures, V12 and treatment time. Either stereotactic radiosurgery or fractionated stereotactic radiotherapy in up to 3 fractions was performed. For MF, a PTV margin of 1 mm was added. Follow-up included quarterly MRI scans. The primary outcome was local control. Secondary endpoints were progression-free survival (PFS), overall survival (OS) and the incidence of radionecrosis. RESULTS: A total of 197 lesions (169 FF and 28 MF) were treated in 76 patients (59 FF and 17 MF). 187 lesions were treated with SRS and 10 with FSRT. Median dose was 22 Gy in both groups and median follow-up was 9.3 months. There was a higher local failure rate (HR: 3.69; 95%CI: 1.13-12.0; p = 0.03) with 11 local failures in the FF and none in the MF cohort. No differences were observed between the groups for OS (median: n.r. vs. 16.9 months; HR:1.00; 95%CI: 0.41-2.46; p = 0.999) and PFS (median: 6.9 vs. 8.4 months; HR: 0.92; 95%CI: 0.47-1.79; p = 0.800). Three cases of radionecrosis occurred with FF but none with MF (p = 0.67). CONCLUSIONS: Gamma Knife treatment with MF does not result in worse outcome or increased rates of radionecrosis in this non-randomized study.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Grimm MA, Köppen U, Stieler F, et al. Prospective assessment of mask versus frame fixation during Gamma Knife treatment for brain metastases. Radiother Oncol. 2020. PMID: 32416280. doi:10.1016/j.radonc.2020.05.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。